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Discussion continues as to whether de novo hypertension in pregnancy with significant
proteinuria (pre-eclampsia; PE) and non-proteinuric new hypertension (gestational
hypertension; GH) are parts of the same disease spectrum or represent different
conditions. Non-pregnant hypertension, pregnancy and PE are all associated with oxidative
stress. We have established a 6 weeks postpartum clinic for women who experienced
a hypertensive pregnancy. We hypothesized that PE and GH could be distinguished
by markers of oxidative stress; thiobarbituric acid reactive substances (TBARS) and
antioxidants (ferric ion reducing ability of plasma; FRAP). Since the severity of PE and
GH is greater pre-term, we also compared pre-term and term disease. Fifty-eight women
had term PE, 23 pre-term PE, 60 had term GH and 6 pre-term GH, 11 pre-existing
(essential) hypertension (EH) without PE. Limited data were available from normotensive
pregnancies (n = 7) and non-pregnant controls (n = 14). There were no differences in
postpartum TBARS or FRAP between hypertensive states; TBARS (P = 0.001) and FRAP
(P = 0.009) were lower in plasma of non-pregnant controls compared to recently-pregnant
women. Interestingly FRAP was higher in preterm than term GH (P = 0.013). In PE
and GH, TBARS correlated with low density lipoprotein (LDL)-cholesterol (P = 0.036);
this association strengthened with inclusion of EH (P = 0.011). The 10 year Framingham
index for cardiovascular risk was positively associated with TBARS (P = 0.003).Oxidative
stress profiles do not differ between hypertensive states but appear to distinguish
between recently-pregnant and non-pregnant states. This suggests that pregnancy may
alter vascular integrity with changes remaining 6 weeks postpartum. LDL-cholesterol is
a known determinant of oxidative stress in cardiovascular disease and we have shown
this association to be present in hypertensive pregnancy further emphasizing that such a
pregnancy may be revealing a pre-existing cardiovascular risk.
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INTRODUCTION
Reactive oxygen species (ROS) are molecules produced from the
reduction of molecular oxygen, generated as by-products of aer-
obic respiration and metabolism. These molecules have diverse
chemical properties and are capable of activating various different
signaling pathways. Major effects of ROS involve the regulation of
physiological processes including cell growth and differentiation,
modulation of extracellular matrix production and breakdown,
as well as inactivation of nitric oxide and stimulation of kinases
(Paravicini and Touyz, 2006). ROS are important in these pro-
cesses but if unchecked, can have destructive effects on cell
components; damagingmembranes by peroxidation of long chain
fatty acids, oxidation and nitration of proteins, and the occur-
rence of DNA lesions/strand breaks. To counterbalance the ROS,
cells have endogenous antioxidant systems in the form of vitamins
C and E, enzymes such as the superoxide dismutase (SOD), cata-
lase and glutathione peroxidase (GPxs) families, polyphenols and
trace elements including copper, zinc, manganese and selenium
(Mistry and Williams, 2011).
Oxidative stress occurs when the production of ROS over-
whelms the antioxidant capacity resulting in overall damage to
cells and has been implicated in the pathology of many hyperten-
sive pregnancy-related conditions including pre-eclampsia (PE)
and gestational hypertension (GH) (Burton and Jauniaux, 2011).
Placentation occurs at low oxygen tensions up to 10 weeks of
gestation (Rodesch et al., 1992; Jauniaux et al., 2000), a hypoxic
environment being essential for trophoblast proliferation and
invasion of the maternal spiral arteries for the restructuring of
these blood vessels. The successful completion of spiral artery
remodeling at around 10–12 weeks’ gestation, results in unplug-
ging of these vessels, which have been transformed into flaccid
conduits with no resistance, enabling uteroplacental blood to
flow unimpeded (Pijnenborg et al., 1991, 2006). This restora-
tion of blood flow results in a rapid rise in the tissue oxy-
gen tension which triggers the production of human chorionic
gonadotrophin (hCG) and enzymes such as P-450 cytochrome
aromatase, involved in the synthesis of oestrogens (Jauniaux et al.,
2006); this gives rise to acceleration of placental tissue growth.
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The rapid increase in oxygenation will also stimulate production
of ROS and concomitant increases in the production and activity
of antioxidant enzymes (Jauniaux et al., 2006).
However, in pathological conditions such as PE, one of the
underlying mechanisms of this condition is the shallow inva-
sion of trophoblasts during these early stages of placentation.
Incomplete remodeling of the spiral arteries leads to intermittent,
more pulsatile, blood flow giving rise to ischaemia/reperfusion–
type injury (Hung and Burton, 2006) with subsequent increases
in ROS. Antioxidant capacity (Madazli et al., 2002; Mistry et al.,
2008, 2010) is lower than in normal pregnancy, further augment-
ing the ROS concentration with the subsequent rise in oxidative
stress so characteristic of PE and other hypertensive-pregnancy
disorders. This shift in antioxidant capacity is a consequence of
inadequate micronutrient status of zinc, manganese and selenium
(Mistry and Williams, 2011) which contribute to the enzyme
activity of antioxidant superoxide dismutases and glutathione
peroxidases (Mistry et al., 2008).
There is an ongoing debate as to whether de novo hypertension
in pregnancy associated with raised protein excretion (PE) is a
different condition to non-proteinuric new hypertension (GH) or
whether it is indeed a different part of a spectrum of the same dis-
ease. GH is defined as elevated blood pressure (SBP≥ 140mmHg
or DBP ≥ 90mm Hg) after 20 weeks of gestation in a previously
normotensive woman (Task Force on Hypertension in Pregnancy,
2013) without proteinuria whereas PE is defined as de novo hyper-
tension with significant proteinuria where there is no evidence of
a urinary tract infection (Brown et al., 2001). Women who expe-
rience GH at term are phenotypically similar to those with mild
essential hypertension (EH) and pregnancy could be acting as a
stress test and unmasking this condition (Williams, 2003). The
risk factors for PE and GH are similar (e.g., type I and gestational
diabetes, high body mass index, twin birth), implying similari-
ties in the biological mechanisms underlying the development of
these conditions, i.e., endothelial dysfunction and inadequate pla-
cental perfusion (Ros et al., 1998).Moreover, between 20 and 50%
of women with early presentation of GH (<36 weeks) go on to
develop PE (Saudan et al., 1998).
There is increasing evidence to suggest that not only are PE and
GH detrimental to the pregnant woman, posing an increased risk
of the accelerated development of cardiovascular disease (CVD;
odds ratio 2.28), cerebrovascular injury (odds ratio 1.76), (Brown
et al., 2013) or end stage renal disease (OR 10.64) (Wu et al.,
2014) they are also associated with sequelae for her offspring,
with a doubling of risk of stroke (odds ratio 1.90) in adult life
(Kajantie et al., 2009; Sutherland et al., 2014). Although this risk
to the mother is not further compounded by a preterm delivery,
early parturition clearly does have consequences for the develop-
ment of the infant. Low birthweight is known to be associated
with increased rates of coronary heart disease and the related dis-
orders, stroke, hypertension and type 2 diabetes (Barker, 2006).
Therefore, there is a serious need to follow up women who
have experienced hypertensive pregnancies even if the pregnancy
continues to term.
As part of a larger study following up women with hyper-
tensive pregnancies (GH, PE, and EH without superimposed
PE), the aims of this present study were to address the specific
questions of whether or not markers of oxidative stress are still
raised inmaternal blood at 6 weeks postpartum and whether their
concentrations differ between the hypertensive states. We hypoth-
esized that oxidative stress markers would still be higher following
the more severe hypertensive states, since this would reflect the
mother’s basic diet and her capacity to synthesize antioxidants.
We assumed that there would no major change in diets before
and after delivery; women with the severest hypertension would
already have inadequate dietary intake and/or inadequate capac-
ity to synthesize endogenous antioxidants such as the glutathione
peroxidases and thus already have an imbalance between ROS
production and antioxidant defenses. In addition, since severity
of PE and GH is greater pre-term (Sibai, 2003), it was also pos-
tulated that oxidative stress profiles would differ in pre-term and
term disease with higher residual oxidative stress in the women
who had delivered preterm.
METHODS
SUBJECTS
All participants provided informed written consent under eth-
ical approval granted by the Nottingham University Hospitals
Research and Development department (ref 10OB002).
Eligible women were recruited to the study at the City Hospital
Maternity Unit between January 2011 and February 2012. All
women attending the unit, who were identified as having hyper-
tension during their pregnancy, were offered a 6-week appoint-
ment at the postnatal hypertension research clinic.
Hypertension was defined as blood pressure (BP)
of >140/90mmHg on two or more occasions >4 h apart;
significant proteinuria ≥0.3 g urinary protein per 24 h or a
spot protein:creatinine ratio (PCR) of over 30 or ≥2+ protein
on urine dipstick, with no evidence of a urinary tract infec-
tion. The diagnostic groups were classified according to the
International Society for the Study of Hypertension in Pregnancy
(ISSHP) guidelines as follows (Brown et al., 2001): preeclamp-
sia (PE)—new hypertension and significant proteinuria ≥20
weeks gestation; gestational hypertension (GH)—new hyperten-
sion≥20 weeks gestation in the absence of significant proteinuria;
essential hypertension (EH)—hypertension ≤20 weeks gestation
or in women already taking anti-hypertensive medication at
booking.
The number of women included in each category were PE:
n = 81(term n = 58, preterm n = 23); GH: n = 66 (term n = 60,
preterm n = 6); EH without superimposed PE: n = 11. Limited
control data on FRAP and TBARS, measured in our labora-
tory, were available, also at the 6 weeks postnatal visit, from 7
women who had enjoyed a normotensive pregnancy and from 14
non-pregnant control women.
LABORATORY INVESTIGATIONS
During the visit, routine clinical laboratory measurements were
carried out; for this sample set the following data are included:
maternal blood pressure, LDL-cholesterol, HDL-cholesterol, total
cholesterol. The women were only 6 weeks postpartum. It was felt
that their compliance with a request to attend the clinic fasting
would be very low. The various plasma cholesterol measurements
are thus random, not fasting.
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OXIDATIVE STRESS MARKERS
Thiobarbituric acid-reactive substances (TBARS)
The measurement of TBARS is a well-established method
for determination of lipid-peroxidation utilizing the reaction
between malondialdehyde (MDA), a product of lipid peroxida-
tion, and thiobarbituric acid (TBA) at temperatures of 90–100◦C.
The pink MDA-(TBA) 2 complex formed is quantified spec-
trophotometrically at 530–540 nm. Results are expressed inμmol
of MDA equivalents. Plasma samples (100μl) were assayed
neat, without dilution and in triplicate using a commercial kit
(Cayman Chemicals 10009055) according to a modified ver-
sion of the manufacturer’s protocol. Following the reaction at
high temperature, the vials were centrifuged for 15–20min,
longer than the recommended time and at room tempera-
ture rather than 4◦C: this minimized cloudiness in the sam-
ples which interfered with the optical density assessments. The
intra- and inter-assay coefficients of variation were 2.1 and 9.1%
respectively.
Ferric reducing ability of plasma (FRAP)
The ferric reducing ability of plasma assay was based on the
method of Benzie & Strain (Benzie and Strain, 1996). At low
pH a ferric-tripyridyltriazine (FeIIITPTZ) complex is reduced
to the ferrous (FeII) form provided a reductant (antioxidant)
is present. In the FRAP assay, excess FeIII is used so that the
rate-limiting factor of the production of the FeII form of the
complex is the reducing ability of the plasma sample. Ascorbic
acid is used as a standard and has a known FRAP value
of 2, the workable assay range was 62.5–1000μM. A reagent
mix consisting of tripyridyltriazine, ferric chloride and acetate
buffer was added to 10μl plasma samples, assayed at a dilu-
tion of 1:2, and incubated at 37◦C. Absorbance of the solu-
tion was measured at 593 nm at time intervals up to 8min
and the change in absorbance calculated and compared to the
standard.
All samples were run blinded as to group and in triplicate. In
our laboratory, the intra- and inter-assay coefficients of variation
were 6 and 13.4% respectively.
10 YEAR FRAMINGHAM INDEX
This index has been developed from the study that originated in
1948 in Framingham, USA (Kannel et al., 1976). A risk score for
developing CVD is calculated from a combination of age, gender,
BP, cholesterol levels, diabetes and cigarette smoking. Historically,
this has been the most commonly used risk score in the developed
world.
STATISTICAL ANALYSES
All tests were performed using IBM SPSS version 21. Data
were tested for normality of distribution using the Kolmogorov-
Smirnov test and appropriate distributional plots. Summary data
are presented as mean [SD] or median [quartiles] as appropri-
ate for the distribution. Between-group comparisons were made
using Mann-Whitney U-tests. Spearman’s Rank correlation test
was used to test for associations between variables.
RESULTS
SUBJECTS
The basal characteristics of the participants are shown in Table 1.
Term delivery was defined as >36 weeks. In the PE preg-
nancies there were 58 term deliveries, median gestational age
39 [IQR 38.3–40.3] and 23 preterm, median gestational age
34.9 [34.4–35.9]; GH term, n = 60, median gestational age 40.0
[38.9–40.9] and GH preterm, n = 6, median gestational age 35
[33.7–36.9].
The non-pregnant controls (n = 14) had a median age and
BMI of 21 [20–23] years and 23.4 [21.7–26.2] kg/m2 respectively.
All were nulliparous.
OXIDATIVE STRESS MARKER (TBARS)
At 6 weeks postpartum, there were no statistically-significant dif-
ferences in the median maternal TBARS concentration between
the hypertensive pregnancy groups: PE 7.6 [IQR 6.1–8.7]; GH
7.3 [5.8–8.6] and EH without PE, 10.5 [7.2–12.4] μM. Mothers
who had delivered preterm (<36 weeks) had comparable plasma
TBARS to mothers who had progressed to term (Figure 1). The
median TBARS concentration in the normotensive pregnancy
Table 1 | Maternal demographic and laboratory parameters.
PE (n = 81) GH (n = 66) EH, no PE (n = 11) Normotensive (n = 7)
Maternal age (years) 29.6±5.9 30.02±6.6 32.2±4.1 29.1±3.7
Gestation at delivery (weeks) 38.0±2.6 39.3±1.9 38.5±1.9 39.7±1.3
BMI (kg/m2) 28.8±5.7 30.8±6.2 30.6±7.2 25.2±6.02
Systolic BP (mmHg) 122.3±11.3 127.8±11.4 135.7±16.7** 105.6±11.9
Diastolic BP—K4 (mmHg) 81.7±8.2 86.2±9.7 92.5±16.1** 68.6±10.8
Smokers [n (%)] (5) 6.2 (5) 7.6 (1) 9.0 (1) 14.0
Breast feeding (%) 32 28 43 71
Antihypertensive medication (%) 10.0 9.2 78.6 0
Total-cholesterol (mmol/L) 4.9 [4.6–5.5] 5.0 [4.5–5.5] 5.4 [5.15–5.8] 5.3 [5.25–5.6]
LDL-cholesterol (mmol/L) 1.5 [1.3–1.7] 1.5 [1.3–1.7] 1.8 [1.7–2.0]* 1.4 [1.4–2.05]
HDL-cholesterol (mmol/L) 2.9 [2.4–3.3] 2.8 [2.4–3.3] 3.0 [2.8–3.6] 3.4 [3.05–3.6]
Framingham 10 year CVD risk score 0.69 [0.47–1.08] 0.81 [0.53–1.38] 1.62 [1.28–1.77]** 0.44 [0.38–0.61]
Values expressed as means ± SD or Median [interquartile range], *P < 0.05; **P < 0.005.
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FIGURE 1 | Lipid peroxidation, measured in units of MDA, shown by
prematurity status in the PE and GH diagnostic groups. No differences
were observed between hypertensive diagnostic groups or between term
and preterm status. The dotted line is the median reference value for
non-pregnant females within this assay.
controls was very similar to that in the PE and GH groups (7.3
[7.1–9.1] μM). However, the median concentration was signif-
icantly lower (4.8 [4.2–6.1] μM) in the non-pregnant controls
than in any of the recently-pregnant groups (P < 0.001).
ANTIOXIDANT CAPACITY (FRAP)
The median overall measure of plasma antioxidant capacity,
FRAP (μM), was also similar in the various categories of
hypertensive pregnancy: PE 1004.4 [IQR 836.6–1282.6]; GH
999.8 [874.0–1252.9] and EH without PE, 905.0 [790.4–1181.4].
Comparing term and preterm PE and GH, FRAP was significantly
higher in the preterm-GH (P = 0.013), (Figure 2).
The normotensive pregnancy controls had significantly higher
median FRAP (P = 0.001) 1209 [1182–1409] than non-pregnant
controls, median 1002 [947–1043]. FRAP concentrations were
significantly lower in the plasma of women who had never been
pregnant compared to the recently-pregnant women (P = 0.009).
ASSOCIATIONS WITH CARDIOVASCULAR RISK
Possible associations with known cardiovascular risk factors were
explored. In PE and GH (pregnancy-specific), there was a signif-
icant correlation between TBARS and LDL-cholesterol at the 6
week visit (P = 0.036; Figure 3): if EH (no PE) was also included,
the correlation was even stronger (r = 0.22, P = 0.011). This
relationship was not apparent when total cholesterol concentra-
tions were considered.
The 10 year Framingham Index is one of two most commonly
used in the UK and is still currently included in the NICE guide-
lines on primary prevention of CVD. Although the participants
enrolled on this study were younger than the Framingham cohort,
it was felt to be the best available index to use. Overall the three
hypertensive categories (PE, GH, and EHwithout PE), the 10 year
Framingham Index showed a positive association with plasma
FIGURE 2 | Antioxidant status, measured as FRAP, shown by
prematurity status in the PE and GH diagnostic groups. Note the
log10scale. Significantly higher antioxidant status in the GH preterm than
the GH term group (P = 0.013). The dotted line is the median reference
value for non-pregnant females within this assay.
FIGURE 3 | The relationship between oxidative lipid peroxidation
(TBARS-MDA) and LDL-cholesterol at 6 weeks postpartum. A significant
positive association was found (R2 = 0.053, r = 0.23, P = 0.011).
TBARS (r = 0.248, P = 0.003; Figure 4). No such association was
observed in the women who had a normotensive pregnancy.
DISCUSSION
This is one of the first large-scale investigations to follow
up hypertensive pregnancies, postpartum. Our analysis of 158
women has demonstrated that TBARS, as markers of serum
oxidative stress, are elevated 6 weeks after delivery compared
to non-pregnant female reference values. This suggests that
the impact of pregnancy on lipid peroxidation may have
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FIGURE 4 | The relationship between lipid peroxidation, measured by
TBARS-MDA, at 6 weeks postpartum, and a cardiovascular disease risk
score, the Framingham 10 year index (R2 = 0.061, r = 0.248,
P = 0.003).
longer-lasting effects than previously thought. The lack of
distinction between the different hypertensive disorders, whether
studied overall or in relation to the timing of disease onset,
was contrary to our hypothesis. However, although, antioxi-
dant capacity, as measured by FRAP, also did not differ between
hypertensive diagnostic groups overall, when assessed 6 weeks
postpartum, FRAP was significantly higher in preterm than term
GH (Figure 2). It was not possible to identify which component
of the antioxidant spectrum was responsible for this increase, but
we speculate that it might represent an increase in synthesis of
endogenous antioxidants, as a protective response to the hyper-
tension. Interestingly, median FRAP in all groups hypertensive in
pregnancy remained somewhat lower than in the controls with
normotensive pregnancy at 6 weeks postnatal.
Previous studies of oxidative stress markers during pregnancy
or at the time of delivery have used comparable measures such as
lipid hydroperoxide and malondialdehyde concentration (Morris
et al., 1998), total antioxidant capacity or biological antioxi-
dant potential (Hsieh et al., 2012; Gomes et al., 2013; Watanabe
et al., 2013). There is a substantial body of evidence showing
that PE is a state of elevated placental oxidative stress (Burton
and Jauniaux, 2011). The rise in circulatory markers is believed
to originate from this placental generation of ROS, contribut-
ing to the ROS generated during the systemic inflammatory
response (Borzychowski et al., 2006). More specific markers of
oxidative stress, such as plasma 8-isoprostane concentrations, are
higher in hypertensive pregnancies compared to normal preg-
nancy, sampled at late gestation or delivery (Hubel, 1999; Rogers
et al., 2006; Bazavilvaso-Rodriguez et al., 2011). As the pathol-
ogy of endothelial dysfunction is a shared characteristic of the
hypertensive disorders of pregnancy, it is not entirely surprising
that a general measure of lipid peroxidation does not distin-
guish between the differing clinical states. Lipid peroxidation
values begin to fall within 24 h of delivery (Little and Gladen,
1999; Gomes et al., 2013). However, the fact that lipid peroxida-
tion appears still to be higher, at 6 week postpartum, in women
who had essential hypertension, as compared to those who had
normotensive pregnancies, suggests that a degree of underlying
damage may have been present before pregnancy in these women.
As the majority of women with EH continued to need anti-
hypertensive medication at the time of the postnatal visit, we
repeated our initial analysis and found that continuing medi-
cation was not associated with any change in either TBARS or
FRAP. There are no known reports of these antihypertensive
medications (labetalol/methyldopa/ atenolol) affecting markers
of oxidative stress per se (Silva et al., 2011). Only one study reports
the calcium channel blocker - nifedipine, as having a lowering
effect on TBARS (Sankar et al., 2005) and then only if given in
combination with sesame oil. It can be seen in Figures 3, 4 that a
group of women, who had both PE and GH, had evidently lower
plasma MDA concentrations than the remainder; we were unable
to identify any other distinguishing feature in these women.
Pregnancy per se leads to an increased oxidative burden as high
maternal and fetal oxygen demand increases oxygen metabolism
(Morris et al., 1998; Roes et al., 2006). Longitudinal studies of
oxidative stress and antioxidant status in pregnancy (Little and
Gladen, 1999; Hung et al., 2010), indicate that lipid peroxides rise
in pregnancy with highest levels of peroxidation markers being
in the 2nd trimester and either being maintained or declining
slightly in the 3rd trimester. Antioxidant status as measured by
FRAP, has been shown to be lower than non-pregnant levels when
considering gestational age earlier than 30 weeks, before increas-
ing toward the end of the 3rd trimester and staying high until
6–8 weeks postpartum(Hung et al., 2010). Our limited data from
non-pregnant controls and normotensive pregnancy are in agree-
ment with this pattern; the reason for its persistence up to 6 weeks
after delivery is not clear. The contribution of dietary antioxidants
to this overall increase cannot be ruled out. Specific endoge-
nous antioxidants, such as ascorbic acid, vitamin E and zinc,
have been analyzed in all three trimesters of normal pregnancies
and shown to be inversely related to gestational age, decreas-
ing gradually as pregnancy proceeds toward term (Patil et al.,
2007; Anetor et al., 2010). Smoking in mothers has a deleterious
effect on both maternal and fetal oxidative and antioxidant status,
increasing free radical damage and decreasing antioxidant poten-
tial (Chelchowska et al., 2011). Nevertheless, it has been reported
that fewer smokers develop PE; those who do, tend to have more
severe disease (Broughton Pipkin and Genetics of Preeclampsia
Consortium, 2008). We included “smoking” as a factor in our
analyses but it did not have an impact on the results in this study.
Our maternal plasma lipid peroxidation data did not show
differences between term and preterm deliveries, although there
was some increase in the median value in PE women who deliv-
ered prematurely (Figure 1); it may be that this parameter is not
a sufficiently sensitive measure of severity within the gestational
range present in this cohort. Normal pregnancy is not only a
state of elevated oxidative stress but also a period of hyperlipi-
demia, with increases in serum total cholesterol, LDL-cholesterol,
HDL-cholesterol, triglyceride, as well as low-density lipoprotein
concentrations (Lippi et al., 2007). In PE, these levels are higher
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than in normal pregnancy (Hubel et al., 1998; Enquobahrie et al.,
2004; Zhou et al., 2014) or the same (Hentschke et al., 2013).
Higher concentrations of LDL-cholesterol have been shown by
large prospective studies such as the Framingham Heart Study to
be positively associated with cardiovascular risk (Gordon et al.,
1977), with HDL-cholesterol being protective. In patients with
coronary heart disease, LDL-cholesterol is a significant determi-
nant of biomarkers of oxidative stress (i.e., reduced/oxidized glu-
tathione and total antioxidant capacity) (Al-Benna et al., 2006).
Therefore, in our study the association between LDL-cholesterol
and TBARS 6 weeks postpartum, in hand with the relationship
between LDL-cholesterol and the 10 year Framingham CVD risk
score, suggests that the damage that ultimately underlies cardio-
vascular and cerebrovascular insults is already present after preg-
nancy, albeit, at a low level. The principal role of LDL-cholesterol
is the transport of cholesterol to cells, where the delivery is taken
up by LDL receptors. The retention of LDL in the arterial intima
of the blood vessel initiates an inflammatory response in the ves-
sel wall (Hansson, 2005). In conditions of oxidative stress, the
LDL is furthermodified by oxidation or enzymic attack within the
intima and subsequent activation of the lectin-like oxidized LDL
receptor-1 (LOX-1) initiates further ROS production, changes
in adhesion molecules (which ultimately induces inflammatory
cells to adhere to blood vessel walls) and endothelial apopto-
sis (Chen et al., 2002). OxLDL rises by 260% in early-onset PE
(Schreurs et al., 2013); the activation of LOX-1 and subsequent
peroxynitrite generation has been postulated as a mechanism
for causing blood-brain barrier disruption and increasing risk
of life-threatening neurological symptoms. A 2 year follow up
study recently published (Zhou et al., 2014), reported that pre-
natal lipoprotein-associated phospholipase A2 (Lp-PLA2) was
elevated in PE, with changes linked to LDL-cholesterol. This
enzyme has been associated with coronary endothelial function
(Lavi et al., 2007). The incidence of postpartum hypertension in
PE was 16% at the 2 year investigation, compared to 1% in the
control normotensive pregnancy group; systolic blood pressure
positively correlated with lipoprotein-associated phospholipase
A2 (Lp-PLA2), an enzyme that hydrolyses LDL to phosphatidyl-
choline and is emerging as a predictive inflammatory marker of
cardiovascular risk.
We are continuing to gather postpartum data from our spe-
cialist clinic, which will also allow us to analyze EH with super-
imposed PE. A limitation of this study is the small number
of normotensive pregnancy controls, arising because women
who enjoyed a normal pregnancy are, understandably, reluc-
tant to attend a specialist clinic. This is being addressed in the
larger cohort. Specific markers of oxidative stress would tar-
get specific pathways of ROS production and may reveal more
regarding mechanisms within each hypertensive disorder, The
8-iso-prostaglandin F2α (PGF2α) is known as an in vivo biomarker
of oxidative stress and can be studied in both plasma and urine
to give more complete information; erythrocyte glutathione-S-
transferases (Orhan et al., 2003) as well as glutathione peroxi-
dases (Orhan et al., 2003) are also often used as oxidative stress
markers. In our observational study we would not be able to
demonstrate prevention of oxidative stress upregulation however
there are number of published studies that indicate that nutrient
supplementation can improve whole blood selenium concentra-
tions (Rayman et al., 2014); protect placental trophoblasts from
oxidative stress (Watson et al., 2012; Khera et al., 2013); and has,
unproven as yet, potential to decrease the risk of PE (Poston et al.,
2011).
Obesity is a risk factor for hypertensive pregnancy and cardio-
vascular disease. The incidence of obesity and being overweight
is a recognized problem in the UK population and the authors
are concerned that almost all the women in this study were over-
weight. This 6 week visit, when the women are coming into
contact with the medical profession, is a window of opportu-
nity for counseling as well as research. It would be of great
benefit to advise these women on the risks of excess weight
and how to lose weight effectively. Specialist clinics with 1 h
appointments, like the research clinic described in this study,
afford the women time to talk about their previous pregnancy
and to discuss lifestyle. In addition, less time-demanding for
the women would be telephone-based weight loss intervention
which has been shown to be effective and sustainable in women
(Kuhlmann et al., 2008; Chasan-Taber et al., 2014; Suksomboon
et al., 2014) or by the more-recently explored option of facebook-
contact (Kernot et al., 2013) or text-messaging (Steinberg et al.,
2013).
There is little doubt now that hypertensive diseases of preg-
nancy are associated with not only short term complications, but
also with longer term cardiovascular and cerebrovascular con-
sequences for both mother and infant. What is not known is
whether these women have underlying disease before pregnancy,
which is unmasked by the pregnancy, or whether the persis-
tent elevation of oxidative stress and cardiovascular risk factors
such as LDL-cholesterol after delivery reflects an impact of preg-
nancy itself. This study supports the idea that persistent changes
are occurring in these conditions and that follow up of these
women is vital to provide risk reduction such as dietary advice
and antioxidant supplementation.
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